Extracorporeal shockwave therapy efficacious for pain and function in knee OA treatment .
This report has been verified
by one or more authors of the
original publication.
Efficacy of extracorporeal shockwave therapy for knee osteoarthritis: a randomized controlled trial
J Surg Res. 2013 Dec;185(2):661-6. doi: 10.1016/j.jss.2013.07.004. Epub 2013 Jul 3070 patients with knee osteoarthritis (OA) were randomized to investigate the effect of extracorporeal shockwave therapy on pain and function associated with OA. Participants were allocated to receive 4 weekly administrations of either ESWT or placebo treatment, and were followed-up up at 12 weeks. The results indicated that the ESWT group experienced significantly greater improvements in pain and function, and had better perception of OA severity at 12 weeks.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
